Safety concerns of herbal products and traditional Chinese herbal medicines: Dehydropyrrolizidine alkaloids and aristolochic acid

Journal of Applied Toxicology

Volumn 35, Issue 12, 2015, Pages 1433-1437

  Stegelmeier, Bryan L ^a   Brown, Ammon W ^a   Welch, Kevin D ^a  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Aristolochic acid; Dehydropyrrolizidine alkaloids; Herb; Herbal medicines; Herbal products; Pyrrolizidine alkaloids; Traditional Chinese medicines

Indexed keywords

ALKALOID DERIVATIVE; ARISTOLOCHIC ACID; DEHYDROPYRROLIZIDINE ALKALOID DERIVATIVE; HELIOTRIDINE; HERBACEOUS AGENT; OTONECINE; PLANT TOXIN; PYRROLIZIDINE DERIVATIVE; RETRONECINE; SENECIONINE; TETRANDRINE; UNCLASSIFIED DRUG; ARISTOLOCHIC ACID I; PYRROLIZIDINE ALKALOID;

CARCINOGENICITY; CHINESE MEDICINE; CONSUMER; DIET SUPPLEMENTATION; DRUG CONTAMINATION; DRUG MARKETING; DRUG SAFETY; HEALTH HAZARD; HERBAL MEDICINE; HUMAN; INTOXICATION; KIDNEY DISEASE; LIVER TOXICITY; MEDICINAL PLANT; NONHUMAN; PREGNANT WOMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TOXICITY TESTING; TOXICOKINETICS; CHEMISTRY; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; GOVERNMENT REGULATION; LEGISLATION AND JURISPRUDENCE; PRODUCT SAFETY; STANDARDS;

ARISTOLOCHIC ACIDS; CONSUMER PRODUCT SAFETY; DRUG CONTAMINATION; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; DRUGS, CHINESE HERBAL; GOVERNMENT REGULATION; HUMANS; PYRROLIZIDINE ALKALOIDS;

EID: 84945464734     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3192     Document Type: Review

References (53)

1. Arlt VM, Stiorova M, Schmeiser HH. 2002. Aristolochic acid as a probably human cancer hazard in herbal remedies: a review. Mutagenesis 17: 265-277.
2. BfR. 2011. Chemical analysis and toxicity of pyrrolizidine alkaloids and assessment of the health risk posed by their occurrence in honey, German Federal Institute for Risk Assessment (BfR) opinion no. 038, 11 pgs.
3. Brown AW, Stegelmeier BL, Colegate SM, Panter KE, Knoppel EL, Hall JO. 2015. Heterozygous p53 knockout mouse model for dehydropyrrolizidine alkaloid-induced carcinogenesis. J. Appl. Toxicol. DOI: 10.1002/jat.3120.
4. Bunchorntavakul C, Reddy KR. 2013. Review article: herbal and dietary supplement hepatotoxicity. Aliment. Pharmacol. Ther. 37: 3-17. DOI: 10.1111/apt.12109.
5. Chan PC, Mahler J, Bucher JR, Travlos GS, Reid JB. 1994. Toxicity and carcinogenicity of riddelliine following 13weeks of treatment to rats and mice. Toxicon 32: 891-908.
6. Chou MW, Fu PP. 2006. Formation of DHP-derived DNA adducts in vivo from dietary supplements and chinese herbal plant extracts containing carcinogenic pyrrolizidine alkaloids. Toxicol. Ind. Health 22: 321-327.
7. Dumic A. 1954. Horse Poisoning with Aristolochic clematitis (in Croatian). Izdanje Vohno Tehnickog Glasnika: Belgrade, Yugoslavia; 3-45.
8. Edgar JA, Colegate SM, Boppre M, Molyneux RJ. 2011. Pyrrolizidine alkaloids in food: a spectrum of potential health consequences. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 28: 308-324.
9. Edgar JA, Molyneux RJ, Colegate SM. 2014. Pyrrolizidine Alkaloids: Potential Role in the Etiology of Cancers, Pulmonary Hypertension, Congenital Anomalies, and Liver Disease. Chem. Res. Toxicol. 28: 4-20. DOI: 10.1021/tx500403t.
10. European Medicines Agency. 2014. Public Statement on the Use of Herbal Medicinal Products Containing Toxic, Unsaturated Pyrrolizidine Alkaloids (PAs). European Medicines Agency: London.
11. EFSA, EFSA Panel on Contaminants in the Food Chain (CONTAM). 2011. Scientific Opinion on Pyrrolizidine alkaloids in food and feed. EFSA J. 9: 1-134. DOI: 10.2903/j.efsa.2011.2406.
12. FSANZ. 2001. Pyrrolizidine alkaloids in food. A toxicological review and risk assessment. Food Standards Australia New Zealand Tech. Report series No. 2, Canberra, Australia.
13. Fu PP, Chiang HM, Xia Q, Chen T, Chen BH, Yin JJ, Wen KC, Lin G, Yu H. 2009. Quality Assurance and Safety of Herbal Dietary Supplements. J. Environ. Sci. Health C 27: 91-119.
14. Griffin CT, Gosetto F, Danaher M, Sabatini S, Furey A. 2014. Investigation of targeted pyrrolizidine alkaloids in traditional Chinese medicines and selected herbal teas sourced in Ireland using LC-ESI-MS/MS. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 31: 940-961. DOI: 10.1080/19440049.2014.900193.
15. Helmy A. 2006. Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndrome. Aliment. Pharmacol. Ther. 23: 11-25. DOI: 10.1111/j.1365-2036.2006.02742.x.
16. Hirono I. 1986. Carcinogenicity of plant constituents: pyrrolizidine alkaloids, flavonoids, bracken fern. Genetic toxicology of the diet. In Proceedings of a Satellite Symposium of the Fourth International Conference on Environmental Mutagens, Knudsen Ib (ed.). A.R. Liss: New York; 45-53.
17. Hirono I, Mori H, Haga M. 1978. Carcinogenic activity of Symphytum officinale. J. Natl. Cancer Inst. 61: 865-868.
18. Hirono I, Ueno I, Aiso S, Yamaji T, Haga M. 1983. Carcinogenic activity of Farfugium japonicum and Senecio cannabifolius. Cancer Lett. 20: 191-198.
19. Hoogenboom LA, Mulder PP, Zeilmaker MJ, van den Top HJ, Remmelink GJ, Brandon EF, Klijnstra M, Meijer GA, Schothorst R, Van Egmond HP. 2011. Carry-over of pyrrolizidine alkaloids from feed to milk in dairy cows. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 28: 359-372. DOI: 10.1080/19440049.2010.547521.
20. Jorg JCG. 1825. Recovered materials and future medicinal remedies collected by Dr. Johann Gottfried Christian Jorg and Carl Cnobloch tested in healthy people (German). Leizig University.
21. Kakar F, Akbarian Z, Leslie T, Mustafa ML, Watson J, van Egmond HP, Omar MF, Mofleh J. 2010. An outbreak of hepatic veno-occlusive disease in Western afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J. Toxicol. 2010: 313280. DOI: 10.1155/2010/313280.
22. Kempf M, Wittig M, Schonfeld K, Cramer L, Schreier P, Beuerle T. 2011. Pyrrolizidine alkaloids in food: downstream contamination in the food chain caused by honey and pollen. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 28: 325-331. DOI: 10.1080/19440049.2010.521771.
23. Kuhara K, Takanashi H, Hirong I, Faraya T, Asada Y. 1980. Carcinogenic activity of clivorine, a pyrrolizidine alkaloid isolated from Ligularis dentata. Cancer Lett. 10: 117-122.
24. Martincic M. 1958. Toxic effects of Aristolochia clematitis on the kidney of the horse (German). Vetererinarski Arhiv 27: 51-59.
25. Mattocks AR. 1986. Chemistry and Toxicology of Pyrrolizidine Alkaloids. Academic Press: Orlando.
26. Mattocks AR, Cabral JR. 1982. Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues. Cancer Lett. 17: 61-66.
27. McQueen CA, Williams GM. 1987. The hepatocyte primary culture/DNA repair test using hepatocytes from several species. Cell Biol. Toxicol. 3: 209-218.
28. Mei N, Guo L, Fu PP, Fuscoe JC, Luan Y, Chen T. 2010. Metabolism, genotoxicity, and carcinogenicity of comfrey. J. Toxicol. Environ. Health B Crit. Rev. 13: 509-526.
29. Moayad YA, Muntaha H. 1998. An outbreak of veno-oclussive disease of the liver in northern Iraq. East. Mediterr. Health J. 4: 142-148.
30. Molyneux RJ, Gardner DL, Colegate SM, Edgar JA. 2011. Pyrrolizidine alkaloid toxicity in livestock: a paradigm for human poisoning? Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 28: 293-307.
31. Newberne PN, Rogers AE. 1973. Nutrition, monocrotaline and aflatoxin b1 in liver carcinogenesis. Plant Foods Manage. 1: 23-31.
32. Newmaster S, Grguric M, Shamnmughanandhan D, Ramalingam S, Ragupathy S. 2013. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med. 11: 1-13.
33. O'Connor A. 2015. New York Attorney General targets supplements at major retailers. The New York Times. http://well.blogs.nytimes.com/2015/02/03/new-york-attorney-general-targets-supplements-at-major-retailers/ [15 March 2015].
34. Pak E, Esrason KT, Wu VH. 2004. Hepatotoxicity of herbal remedies: an emerging dilemma. Prog. Transplant. 14: 91-96.
35. Rasenack R, Muller C, Kleinschmidt M, Rasenack J, Wiedenfeld H. 2003. Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin. Fetal Diagn. Ther. 18: 223-225. DOI:10.1159/000070799.
36. RIVM Rijksinstituut voor Volksgezondheid en Milieu, RIKILT (The Dutch National Institute for Public Health and the Environment). 2005. Advisory report on pyrrolizidine alkaloids in herb preparations, Wageningen, Netherlands. http://www.vwa.nl/txmpub/files/?p_file_id=22703 [15 March 2015].
37. Roeder E. 2000. Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 55: 711-726.
38. Roulet M, Laurini R, Rivier L, Calame A. 1988. Hepatic veno-occlusive disease in newborn infant of a woman drinking herbal tea. J. Pediatr. 112: 433-436.
39. Schoental R. 1968. Toxicology and carcinogenic action of pyrrolizidine alkaloids. Cancer Res. 28: 2237-2246.
40. Schoental R. 1975. Pancreatic islet-cell and other tumors in rats given heliotrine, a monoester pyrrolizidine alkaloid and nicotinamide. Cancer Res. 35: 2020-2024.
41. Schoental R, Head MA, Peacock PR. 1954. Senecio alkaloids: Primary liver tumors in rats as a result of treatment with 1) a mixture of alkaloids from S. jacobaea, lin.; 2) retrorsine; 3) isatidine. Br. J. Cancer 8: 458-465.
42. Stegelmeier BL, Edgar JA, Colegate SM, Gardner DR, Schoch TK, Coulombe RA, Molyneux RJ. 1999. Pyrrolizidine alkaloid plants, metabolism and toxicity. J. Nat. Toxins 8: 95-116.
43. Svoboda DJ, Reddy JK. 1972. Malignant tumors in rats given lasiocarpine. Cancer Res. 32: 908-912.
44. Tandon BN, Tandon HD, Tandon RK, Narndranathan M, Joshi YK. 1976. An epidemic of veno-occlusive disease of liver in central India. Lancet 2: 271-272.
45. Tandon HD, Tandon BN, Mattocks AR. 1978. An epidemic of veno-occlusive disease of the liver in Afghanistan. Pathologic features. Am. J. Gastroenterol. 70: 607-613.
46. United Kingdom Committee on Toxicity of Chemicals in Food CPatEC. 2008. COT statement on pyrrolizidine alkaloids in food. http://cot.food.gov.uk/sites/default/files/cot/cotstatementpa200806.pdf [1 March 2015].
47. US Federal Drug Administration. 2003. Proposal for Dietary Supplements Current: Good Manufacturing Practices (CGMPs). http://www.fda.gov/Food/GuidanceRegulation/CGMP/ucm173996.htm [15 March 2015].
48. US Federal Drug Administration. 2001. FDA Advises Dietary Supplement Manufacturers to Remove Comfrey Products From the Market. FDA Office of Nutritional Products, Labeling and Dietary Supplements. http://vm.cfsan.fda.gov/~dms/dspltr06.html [10 January 2012].
49. Vanherweghem LJ. 1998. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). J. Altern. Complement. Med. 4: 9-13.
50. WHO. 2011. Discussion paper on pyrrolizidine alkaloids, Joint FAO/WHO food standards programme, Codex committee on contaminants in foods. The Hague: The Netherlands.
51. Wiedenfeld H. 2011. Plants containing pyrrolizidine alkaloids: toxicity and problems. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess. 28: 282-292. DOI: 10.1080/19440049.2010.541288.
52. Wiedenfeld H, Roeder E, Bourauel T, Edgar J. 2008. Pyrrolizidine Alkaloids Structure and Toxicity. Bonn University Press: Gottingen.
53. Zurer P, Hanson D. 2004. Chemistry put herbal supplements to the test. Chem. Eng. News 82: 16.